Professionals' treatment goals for long-term benzodiazepine and Z-drugs management: a qualitative study

[en] [en] BACKGROUND: Benzodiazepines and Z-drugs (BZD/Z) are prescribed for longer than recommended. Through their interactions with patients taking BZD/Z, primary care and mental health professionals play a key role in the management of this medication. AIM: To explore how primary care and mental health care professionals set treatment goals with long-term BZD/Z users. DESIGN & SETTING: Semi-structured interviews were conducted, online and in person, with 24 professionals working in mental health and primary care in Belgium. METHOD: Inductive thematic content analysis was performed. RESULTS: Seven themes were identified from the analysis. Professionals tend not to use the DSM-V standard to diagnose a substance use disorder to BZD/Z. They describe criteria based on their experience. They identified diverse types of patients that influence their choice of treatment goals. Professionals appear to position themselves according to their own treatment goals for their patients, either by promoting the goal of abstinence or harm reduction. Some of them report feeling trapped into continuing to prescribe and consider BZD/Z withdrawal to be difficult. Some are afraid to engage in a conversation that might break the bond of trust with the patient. Few professionals mentioned patient participation in the treatment goal setting. They asked for targeted withdrawal recommendations which they perceive to be too broad currently. CONCLUSION: Whether primary care or mental health care professionals are more in favour of a total abstinence or a harm reduction approach to BZD/Z, professionals should be guided towards greater patient participation in setting and evaluating goals with patients taking BZD/Z.

Disciplines :

General & internal medicine
Public health, health care sciences & services

Author, co-author :

Van Ngoc, Pauline ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale

Ceuterick, Melissa ; Hedera, Department of Sociology, Ghent University, Ghent, Belgium

Belche, Jean Luc ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale

Scholtes, Béatrice ; Université de Liège - ULiège > Département des sciences cliniques > Médecine générale

Language :

English

Title :

Professionals' treatment goals for long-term benzodiazepine and Z-drugs management: a qualitative study

Publication date :

19 September 2023

Journal title :

BJGP Open

eISSN :

2398-3795

Publisher :

Royal College of General Practitioners, England

Pages :

BJGPO.2023.0034

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://syndication.highwire.org/content/doi/10.3399/BJGPO.2023.0034

Available on ORBi :

since 26 September 2023

Statistics

Number of views

44 (14 by ULiège)

Number of downloads

22 (5 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

1. Coteur K, Mamouris P, Vaes B, et al. Evolution of benzodiazepine receptor agonist prescriptions in general practice: a registry-based study. Front Public Health 2022; 10: 1014734. DOI: https://doi.org/10.3389/fpubh.2022.1014734
2. Airagnes G, Pelissolo A, Lavallée M, et al. Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep 2016; 18(10): 89. DOI: https://doi.org/10.1007/s11920-016-0727-9
3. Lader M. Benzodiazepines revisited—will we ever learn? Addiction 2011; 106(12): 2086–2109. DOI: https://doi.org/10.1111/j.1360-0443.2011.03563.x
4. Centre Belge d’Information Pharmacothérapeutique. [Hypnotics, sedatives, anxiolytics] Hypnotiques, sédatifs, anxiolytiques (in French) https://www.cbip.be/fr/chapters/11?frag=7476 (accessed 20 Nov 2023).
5. Vlaams Expertisecentrum Alcohol en Andere Drugs (VAD). [Guidelines for prescribing benzodiazepines to users of illicit drugs] Richtlijnen bij het voorschrijven van benzodiazepines aan illegaledruggebruikers (in Dutch). 2023. https://www.vad.be/assets/benzos_inhoudprefin (accessed 20 Nov 2023).
6. Van Der Heyden J, Berete F, Drieskens S. [Conference Presentation] [Medication consumption: 2018 health survey 2018] Consommation de médicaments: Enquête de santé 2018 (in French). Proceedings of the Sciensano. March 2020
7. Kurko TAT, Saastamoinen LK, Tähkäpää S, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns — a systematic review of register-based studies. Eur Psychiatry 2015; 30(8): S0924-9338( 15)00173-X): 1037–1047:. DOI: https://doi.org/10.1016/j.eurpsy.2015.09.003
8. Lader MH. Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 1999; 9(Suppl 6): S399–S405. DOI: https://doi.org/10.1016/s0924-977x(99)00051-6
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorder. Arlington, VA: American Psychiatric Association; 2020.
10. Chen P-L, Lee W-J, Sun W-Z, et al. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS One 2012; 7(11): e49113. DOI: https://doi.org/10.1371/journal.pone.0049113
11. Kang D-Y, Park S, Rhee C-W, et al. Zolpidem use and risk of fracture in elderly insomnia patients. J Prev Med Public Health 2012; 45(4): 219–226. DOI: https://doi.org/10.3961/jpmph.2012.45.4.219
12. Lai M-M, Lin C-C, Lin C-C, et al. Long-term use of zolpidem increases the risk of major injury: a population-based cohort study. Mayo Clin Proc 2014; 89(5): S0025-6196( 14)00106-2): 589–594:. DOI: https://doi.org/10.1016/j.mayocp.2014.01.021
13. Gudex C. Adverse effects of benzodiazepines. Soc Sci Med 1991; 33(5): 587–596. DOI: https://doi.org/10.1016/0277-9536(91)90216-y
14. Kiridis S, Sawchik J, Maenhaut N, et al. Survey on the use of benzodiazepines and Z-drugs to treat insomnia in Belgium. 2022. https://www.fagg.be/sites/default/files/BZRA_study_report_2020_DEF_21.06.2022_0.pdf (accessed20 Nov 2023).
15. Mokhar A, Kuhn S, Topp J, et al. Long-term use of benzodiazepines and Z drugs: a qualitative study of patients’ and healthcare professionals’ perceptions and possible levers for change. BJGP Open 2019; 3(1): bjgpopen18X101626. DOI: https://doi.org/10.3399/bjgpopen18X101626
16. Reuben DB, Tinetti ME. Goal-oriented patient care—an alternative health outcomes paradigm. N Engl J Med 2012; 366(9): 777–779. DOI: https://doi.org/10.1056/NEJMp1113631
17. Boeykens D, Boeckxstaens P, De Sutter A, et al. Goal-oriented care for patients with chronic conditions or multimorbidity in primary care: a scoping review and concept analysis. PLoS One 2022; 17(2): e0262843. DOI: https://doi.org/10.1371/journal.pone.0262843
18. Franklin M, Lewis S, Willis K, et al. Controlled, constrained, or flexible? How self-management goals are shaped by patient–provider interactions. Qual Health Res 2019; 29(4): 557–567. DOI: https://doi.org/10.1177/1049732318774324
19. Heather N. Controlled drinking, harm reduction and their roles in the response to alcohol-related problems. Addiction Research & Theory 2006; 14(1): 7–18. DOI: https://doi.org/10.1080/16066350500489170
20. Cook JM, Marshall R, Masci C. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007; 22(3): 303–307. DOI: https://doi.org/10.1007/s11606-006-0021-3
21. Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995; 36(1): 1–10.
22. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77–101. DOI: https://doi.org/10.1191/1478088706qp063oa
23. Gallagher JR, Whitmore TD, Horsley J, et al. A perspective from the field: five interventions to combat the opioid epidemic and ending the dichotomy of harm-reduction versus abstinence-based programs. Alcohol Treat Q 2019; 37(3): 404–417. DOI: https://doi.org/10.1080/07347324.2019.1571877
24. Brown C, Stewart SH. Harm reduction for women in treatment for alcohol use problems: exploring the impact of dominant addiction discourse. Qual Health Res 2021; 31(1): 54–69. DOI: https://doi.org/10.1177/1049732320954396
25. Sirdifield C, Anthierens S, Creupelandt H, et al. General practitioners' experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract 2013; 14: 191. DOI: https://doi.org/10.1186/1471-2296-14-191
26. Dyas JV, Apekey TA, Tilling M, et al. Patients' and Clinicians' experiences of consultations in primary care for sleep problems and insomnia: a focus group study. Br J Gen Pract 2010; 60(574): e180–e200. DOI: https://doi.org/10.3399/bjgp10X484183
27. Oldenhof E, Anderson-Wurf J, Hall K, Staiger PK. Beyond prescriptions monitoring programs: the importance of having the conversation about benzodiazepine use. J Clin Med 2019; 8(12): 2143. DOI: https://doi.org/10.3390/jcm8122143
28. Fixsen AM, Ridge D. Stories of hell and healing: internet users' construction of benzodiazepine distress and withdrawal. Qual Health Res 2017; 27(13): 2030–2041. DOI: https://doi.org/10.1177/1049732317728053
29. Hawkins EJ, Lott AM, Danner AN, et al. Primary care and mental health prescribers, key clinical leaders, and clinical pharmacist specialists' perspectives on opioids and benzodiazepines. Pain Med 2021; 22(7): 1559–1569. DOI: https://doi.org/10.1093/pm/pnaa435
30. Zolnierek KBH, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care 2009; 47(8): 826–834. DOI: https://doi.org/10.1097/MLR.0b013e31819a5acc
31. Bendtsen P, Hensing G, McKenzie L, Stridsman AK. Prescribing benzodiazepines—a critical incident study of a physician dilemma. Soc Sci Med 1999; 49(4): 459–467. DOI: https://doi.org/10.1016/s0277-9536(99)00133-1
32. Elwyn G, Durand MA, Song J, et al. A three-talk model for shared decision making: multistage consultation process. BMJ 2017; 359: j4891. DOI: https://doi.org/10.1136/bmj.j4891
33. Schlosser AV, Hoffer LD. The psychotropic self/imaginary: subjectivity and psychopharmaceutical use among heroin users with co-occurring mental illness. Cult Med Psychiatry 2012; 36(1): 26–50. DOI: https://doi.org/10.1007/s11013-011-9244-9
34. Mokhar A, Topp J, Härter M, et al. Patient-centered care interventions to reduce the inappropriate prescription and use of benzodiazepines and Z-drugs: a systematic review. PeerJ 2018; 6: e5535. DOI: https://doi.org/10.7717/peerj.5535
35. Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med 2014; 174(6): 890–898. DOI: https://doi.org/10.1001/jamainternmed.2014.949
36. Boeckxstaens P, Boeykens D, Macq J, Vandenbroeck P. Goal-oriented care: a shared language and co-creative practice for health and social care 2020. https://kbs-frb.be/en/goal-oriented-care-shared-language-and-co-creativepractice-health-and-social-care (accessed 20 Nov 2023).